This randomised , blinded , placebo-controlled trial in moderate/severe COPD patients compared once-daily glycopyrronium ( GLY ) 50g , once-daily tiotropium ( TIO ) 18g or placebo ( PLA ) , when combined with salmeterol/fluticasone propionate ( SAL/FP ) 50/500g twice daily .